Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/IT Services/Tata Consultancy Services Share Valuation April 2026
IT Services

Tata Consultancy Services Share Valuation April 2026

By Zumedha Research Team on April 2, 2026 8 Min Read
TCS — Investment Research Report | March 2026
ZUMEDHA EQUITY RESEARCH NSE: TCS | BSE: 532540 | Sector: IT Services | Report Date: March 31, 2026
CMP ₹2,390 ▼ −34% (52W)
52W High ₹3,710
52W Low ₹2,348
Mkt Cap ₹8.65L Cr
Rating ACCUMULATE
Investment Research Report · IT Services · Large Cap
Tata Consultancy
Services Ltd.
India’s AI-Anchored IT Giant — Valuation Reset Creates Entry Opportunity
Exchange NSE / BSE
Sector IT Services
Market Cap ₹8.65 Lakh Cr
Face Value ₹1
Promoter Holding 71.8%
Q4 FY26 Results April 9, 2026
Revenue (FY25)
₹2,55,324 Cr
+6.0% YoY
Net Profit (FY25)
₹48,797 Cr
+5.9% YoY
Operating Margin
24.3%
Industry-leading
ROE
51.2%
Best-in-class
P/E Ratio
~25x
Below 5-yr avg
AI Revenue (Ann.)
$1.8 Bn
+17.3% QoQ (Q3FY26)
TCV Deal Wins (Q3)
$9.3 Bn
Strong order book
Dividend Yield
~3.7%
Includes ₹46 special div
01
Business Overview

Tata Consultancy Services (TCS), founded in 1968 and headquartered in Mumbai, is India’s largest IT services company and the second-largest IT services firm globally by market capitalisation. As the flagship listed entity of the Tata Group, with promoter holding at 71.8%, TCS operates across 55 countries with over 500 offices and 580,000+ employees.

TCS offers a consulting-led, AI-powered portfolio spanning application development, digital transformation, cloud services, cybersecurity, enterprise solutions (ERP), engineering services, and business process outsourcing. Its proprietary platforms — TCS BaNCS (BFSI), ignio (cognitive automation), TCS iON (education), TCS OmniStore (retail), and the newly announced HyperVault (data centres) — deepen client lock-in and expand the addressable market.

Revenue is broadly diversified: BFSI (31.9%), Consumer Business (15.4%), Life Sciences & Healthcare (10.5%), Manufacturing (8.8%), Technology & Services (8.4%), Communication & Media (5.9%), and Energy, Resources & Utilities (6.0%). Geographically, North America contributes approximately 48%, Europe ~31%, and the rest of the world ~21%.

The company’s strategic pivot is unambiguous: TCS aims to become the world’s largest AI-led technology services company, guided by a five-pillar AI strategy — AI Horizons, AI for Industry, AI for Enterprise, AI in Operations, and HyperVault. With over 217,000 associates now certified in AI skills, TCS is aggressively repositioning its talent and delivery model for the next technology cycle.

02
Historical Financial Performance
MetricFY22FY23FY24FY25Q3 FY26
Revenue (₹ Cr)1,91,7542,25,4582,40,8932,55,32467,087
Revenue Growth YoY16.8%17.6%6.8%6.0%4.9% YoY
Operating Margin25.0%24.1%24.6%24.3%25.2%
Net Profit (₹ Cr)38,44942,30346,09948,79710,657*
Net Profit Growth—10.0%9.0%5.9%−13.9% YoY*
5-yr PAT CAGR10.6%

*Q3 FY26 net profit decline is due to exceptional items: ₹2,130 Cr new labour law charge + ₹1,010 Cr legal provision. Underlying performance remains intact. Margins improved to 25.2% in Q3 FY26 — highest since FY22.

Operationally, TCS has demonstrated remarkable consistency over a decade. Despite the global IT demand slowdown through FY24–FY25, the company defended margins at the 24–25% band while maintaining industry-best attrition metrics (13.5% LTM). Cash conversion remains exceptional: FY25 operating cash flow hit ₹48,908 Cr, the highest in three years, with free cash flow of ₹46,449 Cr. The company’s balance sheet is net-cash positive with a debt-equity ratio of −0.39.

USD revenue has been under pressure: FY25 USD revenue of $30,179 Mn reflected only +3.8% growth as rupee tailwinds offset the constant-currency drag. Q3 FY26 USD revenue was $7,509 Mn, down 0.4% YoY in USD terms. This macro currency headwind is transient and does not alter the structural INR revenue trajectory.

03
DCF Valuation
DCF
10-Year Free Cash Flow Discounted Valuation
Base FCF (FY25)
₹46,449 Cr
FCF Growth (Yr 1–5)
10% p.a.
FCF Growth (Yr 6–10)
8% p.a.
WACC
12%
Terminal Growth Rate
5%
Intrinsic Value / Share
₹3,050–₹3,200
Shares outstanding: ~362.3 Cr | CMP: ₹2,390 | Implied upside from DCF midpoint: ~30% | EV/EBITDA: ~17.6x (peer avg: 15–19x) | P/E: ~25x vs. 5-yr avg of ~32x — stock at deep valuation discount to history.

At current market price of ~₹2,390, TCS trades at approximately 25x trailing earnings and 17.6x EV/EBITDA — both well below its 5-year average multiples of 32x P/E and 22x EV/EBITDA respectively. The compression reflects: (1) weak USD revenue growth, (2) global IT demand caution, and (3) Nifty IT sector de-rating. Our DCF, anchored to conservative FCF growth assumptions and a 12% WACC, yields an intrinsic value band of ₹3,050–₹3,200 per share, suggesting ~28–34% upside over 12–18 months. Sell-side consensus (44 analysts) has an average 12-month target of ₹3,518, with a high of ₹4,810.

04
Buy Range
▲ BUY ZONES — Based on DCF & Historical Valuation Bands
Strong Buy
Below ₹2,400
P/E <24x · Maximum margin of safety · Deploy aggressively
Accumulate
₹2,400–₹2,800
P/E 24–28x · Fair entry · SIP-style accumulation
Fair Value
₹2,800–₹3,200
P/E 28–32x · Near intrinsic value · Hold existing

At the current CMP of ₹2,390, TCS sits squarely in the Strong Buy zone — the first time the stock has revisited these valuation levels since 2022. The combination of a 34% drawdown from the 52-week high, a dividend yield of ~3.7%, and a robust AI-driven order book makes this an exceptional risk-reward entry point for long-term investors.

05
Buy Scenario Analysis
Bear Case
₹2,200
−8% from CMP
Global recession deepens; BFSI spending cuts, AI hype turns to budget freeze, USD weakens further. Revenue growth stalls at 2–3%, margins compress to 22%. P/E re-rates to 20x.
Base Case
₹3,140
+31% from CMP
IT spending recovery accelerates in H2 FY27; AI services hit $3Bn run-rate; USD revenue recovers to 7–8% growth. Margins hold at 24–25%. P/E re-rates to 28–30x on FY27E earnings.
Bull Case
₹4,000
+67% from CMP
AI-led transformation creates a new mega-deal cycle; TCS wins large GenAI transformation mandates; HyperVault data centre business matures; re-rating to 35x P/E on FY27E earnings of ₹115/share.
06
Sell Range
▼ SELL / REDUCE ZONES — Exit Triggers Based on Overvaluation or Fundamentals
Reduce
₹3,500–₹3,800
P/E 35–38x · Approaching fair value ceiling · Trim 25–30% of position
Exit / Book Profits
₹3,800–₹4,200
P/E 38–42x · Significant overvaluation · Exit unless AI story re-rates
Avoid / Short Bias
Above ₹4,200
P/E >42x · Euphoria territory · Unsustainable unless paradigm-shift earnings
07
Sell Scenario Analysis
Overvalued
Euphoric Re-rating
Stock rallies to ₹4,000+ on AI hype without fundamental earnings delivery. P/E expands to 40x+ without corresponding EPS growth. Reduce/exit on multiple expansion alone.
Exit Trigger
Margin Collapse
Sustained margin erosion below 22% EBIT due to wage inflation, AI commoditisation, or competitive pricing pressure. Signals structural deterioration in profitability model.
Structural Break
AI Disruption Risk
Generative AI displaces large chunks of traditional IT services (maintenance, testing, support). If TCV deal wins fall below $7Bn/quarter for two consecutive quarters, re-evaluate the thesis.
08
Future Growth & Earnings Potential

TCS’s growth trajectory over FY26–FY28 is anchored on three structural themes: (1) AI services monetisation — annualised AI revenue already at $1.8Bn growing 17% QoQ in CC, with the target of becoming the world’s largest AI-led IT firm; (2) Deal momentum — TCV signed of $9.3Bn in Q3 FY26 despite a weak macro; the pipeline includes large AI transformation mandates from BFSI and manufacturing clients; (3) HyperVault — TCS’s new data centre business is gaining traction with enterprise clients who need sovereign AI infrastructure.

We expect FY26E revenue of ~₹2,65,000 Cr (+4–5% YoY), with FY27E and FY28E accelerating to ~₹2,88,000 Cr and ~₹3,15,000 Cr respectively as the IT demand cycle turns. EPS is expected to recover to ₹95–100 in FY26E, ₹108–115 in FY27E and ₹125–130 in FY28E, implying the stock currently trades at just 21x FY27E earnings — a compelling valuation for a company with 24%+ EBIT margins and 51% ROE.

MetricFY25AFY26EFY27EFY28E
Revenue (₹ Cr)2,55,3242,65,0002,88,0003,15,000
Revenue Growth6.0%~4–5%~8–9%~9–10%
EBIT Margin24.3%24.5%25.0%25.5%
EPS (₹)~134~95–100~108–115~125–130
P/E at CMP ₹2,390~17.8x~24x~21x~18.5x

FY26E EPS adjusted for exceptional items (₹3,391 Cr in Q3 FY26 alone). FY25A EPS shown on reported basis; note FY25 PAT includes some one-off other income items.

09
Risks & Catalysts
Catalysts (Bull Factors)
AI services revenue scaling rapidly — $1.8Bn annualised, growing 17% QoQ
Strong deal TCV pipeline ($9.3Bn in Q3); large GenAI mandates in pipeline
BFSI sector green shoots — 31.9% of revenue starting to recover
HyperVault data centre business unlocking new high-margin revenue streams
Valuation at a 5-year low (25x P/E vs. 32x historical avg) offers mean reversion upside
Exceptional dividends (₹57/share Q3 special payout) reward patient holders
Fortune “World’s Most Admired Companies” — brand moat and client trust
Risks (Bear Factors)
USD revenue declining YoY (−0.4% Q3 FY26); USD/INR movements remain a headwind
GenAI disrupts traditional IT services — testing, maintenance and support headcount under threat
Headcount declined by 11,151 in Q3; attrition normalising but hiring muted
US macro uncertainty and tariff-related corporate spend freeze could delay decision-making
SG&A expenses rose to 15.6% in Q3 vs. 14.3% two quarters prior — cost creep risk
North American concentration (~48% revenue) exposes TCS to US tech spend cycles
Recurring exceptional items risk market confidence in earnings quality
10
Peer Comparison
CompanyMkt Cap (₹Cr)P/EEV/EBITDARevenue GrowthEBIT MarginROE
TCS8,65,00025x17.6x6.0% (FY25)24.3%51.2%
Infosys~5,30,00024x15.8x~5.5%21.0%~32%
HCL Technologies~3,70,00025.5x16.5x~7.5%17–18%~24%
Wipro~2,50,00022x14.0x~1.1%16–17%~15%
Tech Mahindra~1,35,00028x16.0x~3–4%10–12%~12%

TCS commands a premium among peers on the strength of its superior margins (24.3% EBIT vs. sector average of ~18%) and exceptional ROE (51% vs. peer range of 12–32%). Despite this quality premium, it currently trades at a P/E in line with Infosys and HCL Technologies — representing an anomaly. Historically, TCS has traded at a 20–30% premium to Infosys; this gap has narrowed materially in the current cycle, creating a reversion opportunity.

◆ ANALYST VERDICT
TCS is a rare blue-chip that has handed investors a 34% drawdown from its 52-week peak — not because of any structural deterioration, but due to cyclical IT sector headwinds, USD revenue pressure, and one-time exceptional items that clouded Q3 FY26 earnings. Beneath the noise, the operating reality is compelling: industry-best 24–25% EBIT margins, a $9.3Bn quarterly deal TCV, rapidly scaling AI services at $1.8Bn annualised revenue, and a balance sheet that generates ₹48,900 Cr in operating cash flow annually. At 25x trailing P/E — the lowest in five years — TCS offers exceptional risk-adjusted upside to patient, long-horizon investors. We initiate coverage with an ACCUMULATE rating, with a 12-month base-case target of ₹3,140 and a bull-case of ₹4,000 on an AI re-rating cycle.
ACCUMULATE
12-Month View
Base Target
₹3,140
Upside from CMP
+31.4%
Bull Case: ₹4,000 | Bear: ₹2,200
DISCLAIMER: This report is produced for informational and educational purposes only and does not constitute investment advice, a solicitation, or an offer to buy or sell any security. The analysis and opinions expressed herein are based on publicly available information and the author’s independent research. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Readers should consult a SEBI-registered investment advisor before making any investment decisions. The author or publisher may or may not hold positions in the securities mentioned. Market cap, price, and financial data are approximate as of March 31, 2026. Estimates and forecasts are projections and may differ materially from actual outcomes. SEBI Registration: Not applicable — this is independent research. This report is not endorsed by TCS, Tata Group, or any affiliated entity.

Tags:

Large Cap StocksNifty 50
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Suven Life Sciences Value Analysis March 2026

Next

TVS Motors Value Analysis March 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS